Cargando…

Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis

BACKGROUND: : The gene mutation of coding sodium channel is one of the most important mechanisms in the pathogenesis of epilepsy. There exists a large inter-individual variation in the efficacy of valproic acid (VPA) against epilepsy. What are the genetic polymorphism influences of sodium channels o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Zhuangfei, Chen, Jiang, Zhu, Bin, Lu, Yan, Chen, Lijiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136989/ https://www.ncbi.nlm.nih.gov/pubmed/34011048 http://dx.doi.org/10.1097/MD.0000000000025831

Ejemplares similares

Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy
por: Lu, Yuan, et al.
Publicado: (2020)

Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case–control study and meta-analysis
por: Wang, Zhi Jian, et al.
Publicado: (2018)

SCN1A polymorphisms influence the antiepileptic drugs responsiveness in Jordanian epileptic patients
por: Abduljabbar, Rami, et al.
Publicado: (2023)

SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epileptic patients
por: Namazi, Soha, et al.
Publicado: (2015)

Association Between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 Polymorphisms and Responsiveness to Antiepileptic Drugs: A Meta-Analysis
por: Li, Mengmeng, et al.
Publicado: (2021)

Recurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015)

Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015)

Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathy
por: Kambouris, Marios, et al.
Publicado: (2016)

The possible effect of SCN1A and SCN2A genetic variants on carbamazepine response among Khyber Pakhtunkhwa epileptic patients, Pakistan
por: Nazish, Haleema Rehana, et al.
Publicado: (2018)

Cardiovascular risk factors in children and adolescents with subclinical hypothyroidism: A protocol for meta-analysis and systematic review
por: DENG, Huan, et al.
Publicado: (2020)

Dietary supplements for prediabetes: A protocol for a systematic review and meta-analysis
por: Liu, Dongying, et al.
Publicado: (2020)

A Complex Genomic Rearrangement Resulting in Loss of Function of SCN1A and SCN2A in a Patient with Severe Developmental and Epileptic Encephalopathy
por: Orlando, Valeria, et al.
Publicado: (2022)

Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus risk in children: A protocol for systematic review and meta-analysis
por: Ran, Yalin, et al.
Publicado: (2021)

Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes: A meta-analysis
por: Zhuang, Yan, et al.
Publicado: (2020)

Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy
por: Thompson, Jeremy A., et al.
Publicado: (2022)

Large-scale structural alteration of brain in epileptic children with SCN1A mutation
por: Lee, Yun-Jeong, et al.
Publicado: (2017)

Effects of inositol and alpha lipoic acid combination for polycystic ovary syndrome: A protocol for systematic review and meta-analysis
por: Lei, Wenwen, et al.
Publicado: (2020)

SCN1B‐linked early infantile developmental and epileptic encephalopathy
por: Aeby, Alec, et al.
Publicado: (2019)

SCN8A Mutation in Infantile Epileptic Encephalopathy: Report of Two Cases
por: Fatema, Kanij, et al.
Publicado: (2019)

Case Series of Early SCN1A-Related Developmental and Epileptic Encephalopathies
por: Gowda, Vykuntaraju Kammasandra, et al.
Publicado: (2021)

Assessment of the efficacy of α-lipoic acid in treatment of diabetes mellitus patients with erectile dysfunction: A protocol for systematic review and meta-analysis
por: Cai, Jiawei, et al.
Publicado: (2020)

Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy
por: Miao, Pu, et al.
Publicado: (2020)

Association between polymorphisms in microRNAs and susceptibility to diabetes mellitus: A meta-analysis
por: Chen, Xi, et al.
Publicado: (2019)

Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Wang, Xian, et al.
Publicado: (2020)

Ascorbic acid supplementation in type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Shi, Lipeng, et al.
Publicado: (2020)

Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis
por: Liu, Jie, et al.
Publicado: (2020)

Lack of association between BDNF rs6265 polymorphism and risk of type 2 diabetes: A protocol for meta-analysis and trial sequential analysis
por: Xie, Xian-Qiong, et al.
Publicado: (2021)

Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus
por: Cho, Eun-Hee, et al.
Publicado: (2020)

Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015)

Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

Effects of vitamin and omega-3 fatty acid co-supplementation on blood glucose in women with gestational diabetes mellitus: A protocol for systematic review and meta analysis
por: He, Lei, et al.
Publicado: (2021)

Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis
por: Shi, Xiao-yan, et al.
Publicado: (2020)

Acupoint injection therapy for diabetic retinopathy: A protocol for systematic review and meta-analysis
por: Zhou, Yanni, et al.
Publicado: (2021)

Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
por: Wang, Shengju, et al.
Publicado: (2020)

Retinal blood oxygen saturation and vascular endothelial growth factor-A in early diabetic retinopathy: A protocol for systematic review and meta-analysis
por: Qiu, Xianliang, et al.
Publicado: (2020)

Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
por: Sourbron, Jo, et al.
Publicado: (2017)

Ketogenic Diet in Infants with Early-Onset Epileptic Encephalopathy and SCN2A Mutation
por: Tian, Xiaoyu, et al.
Publicado: (2021)

Persistent sodium currents in SCN1A developmental and degenerative epileptic dyskinetic encephalopathy
por: Gorman, Kathleen M, et al.
Publicado: (2021)

Metformin and acupuncture for polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Gao, Yang, et al.
Publicado: (2020)

Data on mutations and Clinical features in SCN1A or SCN2A gene
por: Kong, Yanting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4m9od0q6ffpstg85usu2cduvvt